JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 4 April 2005. doi:10.1083/jcb1691iti5
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 169, Number 1, 15-15
This Article
Right arrow Full Text (PDF, 506K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuma, R. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tuma, R. S.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

Signal for ER-associated degradation



CPY{Delta}1 is a poor substrate for ERAD because it lacks a vital sugar.

A major pathway for misfolded proteins is the ER-associated degradation (ERAD) pathway. On page 73, Spear and Ng show that misfolding is not enough to target a protein to ERAD. Rather, particular sugar residues act as signals.

The team used a shortened CPY protein as a model unfolded protein. CPY{Delta}1 lacked the terminal 154 amino acids of the protein. Surprisingly, it was retained in the ER, rather than being targeted for ERAD. Although CPY contains four N-glycosylation sites, the team found that if they disrupted the last site—the one missing in CPY{Delta}1—the protein was retained in the ER.To further test whether a single glycan could act as a signal for degradation, the team created two novel mutations in the ERAD substrate proteinase A*. When they mutated the first of two N-glycosylation sites in the protein, it was retained in the ER, like CPY{Delta}1; but mutating the second site had no effect.

The team has started to further narrow down the features of the glycosylation sites that act as ERAD-entry signals. They have preliminary evidence that it is a bipartite signal, with a polypeptide sequence acting in conjunction with the sugar. If they move both together they can transfer the ERAD-targeting signal, independent of the rest of the protein. Remarkably, the glycosylation sites identified by Spear and Ng do not appear to have a function in the correctly folded protein, suggesting that they evolved for the purpose of targeting the protein for degradation when it misfolds. {iti_end}



Rabiya S. Tuma

rabiya{at}nasw.org


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Single, context-specific glycans can target misfolded glycoproteins for ER-associated degradation
Eric D. Spear and Davis T.W. Ng
J. Cell Biol. 2005 169: 73-82. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 506K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuma, R. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tuma, R. S.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents